Web Analytics Made Easy - StatCounter
GeM Registration
Advance Search

Cytosine Arabinoside Inj Tenders

Get complete information related to latest Cytosine Arabinoside Inj Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Cytosine Arabinoside Inj Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Cytosine Arabinoside Inj Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Get Tender in Email

corporations/Associations/Others

CTN :44434778 Due date: 12 May, 202612 May, 2026 NA
Location: Delhi - Delhi Delhi - Delhi
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

CTN :44793635 Due date: 29 Apr, 202629 Apr, 2026 NA
Location: Balangir - Odisha Balangir - Odisha
Tender For corrigendum : procuring drugs, consumables, equipment, and other components. inj. aceclofenac 150mg/ml , inj. acetylcysteine 200mg/ml 10ml/amp , inj. acyclovir sodium intravenous infusion ip 250mg , inj. adalimumab 40mg/0.8ml pfs , inj. adenosine 3 mg/ml , inj. adrenaline bitartrate img/ml , inj. amikacine sulphate 100mg/2ml , ini. amikacine sulphate 500mg/2ml , inj. amino acid 7% , inj. amino acid infusion pure crystalline essential aminoacid i.v. infusion 200ml , inj. amino acid infusion pure crystalline essential aminoacid i.v. , infusion 20ml , inj. aminophylline 25mg/ml , inj. amiodarone 50mg/ml 3ml/vials , inj. amoxycilline & potassium clavulanate ip 1.2 gm , inj. amphotericine b liposomal (with diluents in plastic container)-50 mgvial , inj. ampiciline 250mg cloxacilline 250mg , inj. ampicillin 100mg/vial , inj. ampiciline 500mg/vial , inj. ampicilline 1gm cloxacilline 500mg , inj. anti rabis vaccine for human use with diluents 2.5 iu/vial , inj. artemether 150mg/2ml , inj. artesunate-60 mg/vial (with sodium bi-carbonate 1ml-5ml nacl) , inj. atracurium besylate-10 mg/ml 2.5ml/amp. , inj. atropine iv 1mg/ml 100ml/bottis , inj. atropine sulphate 0.6mg/ml , inj. azithromycine 500mg/vial , inj. aztreonam 1gm. , vecuronium powder for injection 10mg , vecuronium powder for injection 4mg , inj capreomycin igm , inj capreomycin 750mg , inj capreomycin 500mg , inj. benzathine penicillin 6 lu/vial , inj. benzathine penicillin 12lu/vial , inj.betamethasone sod. phosphate 4mg/ml , inj. biphasic isophane insulin 40 units (50:50) 10ml , inj. carfilzomib 60mg , inj. caspofungin 50mg/vial , inj. cefazolin 1gm , inj. cefazolin 500mg , inj. cefepime 1gm/vial , inj. cefipime 500mg , inj. cefipime tazobactum 1.125gm , inj. cefoperazone 1000mg (with 10ml diluents) , inj. cefoperazone igm & sulbactum 1000mg (10ml/vial) , inj. cefoperazone igm & sulbactum 500mg (10ml/vial) , inj. cefoperazone 500mg & sulbactum 500mg(10ml/vial) , inj. cafoperazone 250mg& sulbactum 250mg , inj. cefotaxim sodium 125mg/vial , inj. cefotaxim sodium 1gm/vial , inj. cefotaxim sodium 250mg/vial , inj. cefotaxim sodium 500mg/vial , inj. ceftazidime 1gm , inj. ceftriaxone 1gm/vial , inj. ceftriaxone 1gm+ salbactum 500mg 10ml/vial , inj. ceftriaxone 1gm + tazobactum 500mg 10ml/vial , inj. ceftriaxone 250mg/vial , inj. cefuroxime axetil 1.5gm , inj. ciproflusacin iv 100ml buttle , inj. cis-atracurium, 2mg/ml/5ml/vials , inj. citicolin 250mg/ml 2ml , inj. clarithromycine 500mg , inj. clindamycine 300mg , inj. clindamycine 600mg , inj. compound sodium lactate (500ml) (rl-lactic acid-0.24 w/v,eqivalent to 0.32% w/v of sodium lactate sodium chloride-0.6%w/v, potassium chloride 0.04% w/v calcium chloride 0.027% w/v) , inj colchicine 0.5mg/ml 2ml/amp , inj. colistimethate sodiumfor i.v. infusion only 2m unit , inj. dacarbazine 500mg , inj. deferrioxamine 2gm , inj. dexamethasone 4mg/ml 2ml/vial , inj. dexmedetonidine 200mcg/2ml , inj. dextrose & sodium chloride (500ml) 5%+0.9% w/v , inj. dextrose 25% w/v (100ml) , inj. ephedrine hcl 30mg/ml , inj. equine rabies immunoglobuline 1500 iu/sml , inj erythropoietin (epo)-10000 iu/pfs, 10000 iu/pfs , inj. erythropoietin (epo)-4000 iu/pfs.4000 iu/pfs , inj. erythropoietin (epo)-2000 iu/pfs 2000 iu/pfs , inj. esmolol 10mg/ml (100mg/10ml/vial) , inj. etanercept 50mg/1ml pfs , inj. ethacridine lactate 1mg/ml 50ml/bott. , inj. ethamsylate 125mg/ml , inj. etomidate 2mg/ml 10ml/vials , inj. exenatide smcg/1.2ml , inj. factor ix (plasma free, human albumin free)-500 iu/ , inj. factor ix (with diluents in plastic or glass container)-600 iu , inj. factor vii (recombinant) (with diluents in plastic or glass container) , inj. factor vill (with diluents in pleatic or glass container)-250 iu , inj. factor viii (with diluents in plastic or glass container)-500 iu , feracrylurn 1% antiseptic solution , inj. ferric carboxy maltose500mg , inj. fluconazole 200mg/100ml , inj. flumazenil u.smg/sml , inj. fondaparinux 2.5mg/0.5ml ,

Central Government/Public Sector

CTN :44661457 Due date: 22 Apr, 202622 Apr, 2026 NA
Location: Multi City - Multi State Multi City - Multi State
Tender For supply of atracurium besylate 10 mg per ml injection 2.5 ml[quantity tolerance (+/-): 0 %age , item category : normal , total po value variation permitted: max 8 lacs ]
 Loading, Please wait...

Connect us via What's Up